133 related articles for article (PubMed ID: 31912408)
21. Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
Hodžić H; Bajramović A; Obradović Z; Mahmić-Kaknjo M
Med Glas (Zenica); 2017 Feb; 14(1):73-78. PubMed ID: 28165441
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and knowledge of sexual transmitted infections, drug abuse, and AIDS among male inmates in a Taiwan prison.
Feng MC; Feng JY; Chen YH; Chang PY; Lu PL
Kaohsiung J Med Sci; 2012 Dec; 28(12):660-6. PubMed ID: 23217358
[TBL] [Abstract][Full Text] [Related]
24. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
25. Characterizing the relationship between incarceration and structural risks among female sex workers in Iran: findings of a nationwide biobehavioral surveillance survey.
Karamouzian M; Shokoohi M; Kaplan RL; Noroozi A; Sharifi H; Baral SD; Mirzazadeh A
Ann Epidemiol; 2019 Jul; 35():29-34. PubMed ID: 31171443
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
27. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
28. HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in Sindh, Pakistan.
Baqi S; Nabi N; Hasan SN; Khan AJ; Pasha O; Kayani N; Haque RA; Haq-IU ; Khurshid M; Fisher-Hoch S; Luby SP; McCormick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 May; 18(1):73-9. PubMed ID: 9593461
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
30. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
[TBL] [Abstract][Full Text] [Related]
31. HIV sexual risk behaviors among injection drug users in Shanghai.
Zhao M; Du J; Lu GH; Wang QY; Xu H; Zhu M; McCoy CB
Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S43-7. PubMed ID: 16769445
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence and Related Risk Behaviors of Hepatitis C, Hepatitis B and HIV Infections among Male Prisoners in Kermanshah, Iran.
Khademi N; Skakiba E; Khodadoust M; Khoramdad M
Arch Iran Med; 2019 Oct; 22(10):588-591. PubMed ID: 31679361
[TBL] [Abstract][Full Text] [Related]
33. HIV risk behaviour correlates among injecting drug users in Greek prisons.
Koulierakis G; Gnardellis C; Agrafiotis D; Power KG
Addiction; 2000 Aug; 95(8):1207-16. PubMed ID: 11092068
[TBL] [Abstract][Full Text] [Related]
34. Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia.
Martin RE; Gold F; Murphy W; Remple V; Berkowitz J; Money D
Can J Public Health; 2005; 96(2):97-101. PubMed ID: 15850026
[TBL] [Abstract][Full Text] [Related]
35. Methadone maintenance therapy outcomes in Iran.
Noori R; Narenjiha H; Aghabakhshi H; Habibi G; Khoshkrood Mansoori B
Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
[TBL] [Abstract][Full Text] [Related]
36. Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study.
Winter RJ; Stoové M; Agius PA; Hellard ME; Kinner SA
Drug Alcohol Rev; 2019 Mar; 38(3):254-263. PubMed ID: 30569550
[TBL] [Abstract][Full Text] [Related]
37. HIV risk behavior among injection drug users in Tehran, Iran.
Razani N; Mohraz M; Kheirandish P; Malekinejad M; Malekafzali H; Mokri A; McFarland W; Rutherford G
Addiction; 2007 Sep; 102(9):1472-82. PubMed ID: 17645427
[TBL] [Abstract][Full Text] [Related]
38. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons.
van Haastrecht HJ; Bax JS; van den Hoek AA
Addiction; 1998 Sep; 93(9):1417-25. PubMed ID: 9926547
[TBL] [Abstract][Full Text] [Related]
39. Correlates of property crime in a cohort of recently released prisoners with a history of injecting drug use.
Kirwan A; Quinn B; Winter R; Kinner SA; Dietze P; Stoové M
Harm Reduct J; 2015 Aug; 12():23. PubMed ID: 26238245
[TBL] [Abstract][Full Text] [Related]
40. Alcohol use disorder among prisoners in Debre Berhan prison, Ethiopia: a cross-sectional study.
Haile YG; Kebede KB; Limenhe A; Habatmu K; Alem A
Subst Abuse Treat Prev Policy; 2020 Apr; 15(1):26. PubMed ID: 32245385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
